Biopharma giants Eli Lilly and Regeneron and rapidly growing contract manufacturers Fujifilm and Cellares are among the seven companies
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
FDA taps Lilly, Fujifilm and five more for its factory-speeding PreCheck pilot
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
Eli Lilly, Regeneron Join FDA Pilot Designed To Accelerate US Manufacturing Readiness - Eli Lilly (NYSE:L
FDA picks Eli Lilly, Regeneron, Fujifilm, Cellares, Amneal, Kriya and Kyowa Kirin for its PreCheck pilot to speed US…
Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has learned.
FDA names seven companies to its PreCheck pilot to speed U.S. drug manufacturing reviews after receiving more than 80…
As China-developed assets gain more attention from biopharma dealmakers, some industry watchers want to cur | As China-developed…
With China's growing dominance in the biopharma R&D sector, a collection of g | A group of over 20 global pharma leaders met with…
Modern drug development demands faster, more scalable gene expression insights. Download this white paper to explore how…
